ENTITY

Ionetix (IONTX US)

3
Analysis
Health Care • United States
Ionetix Corporation develops superconducting cyclotron technology for medical and industrial applications. The company generates revenue from diagnostic radioisotopes, such as PET imaging isotopes F-18, Ga-68, and N-13, and therapeutic alpha-emitting isotopes like Ac-225 and At-211, while also exploring other applications for its particle accelerator technology.
more
bullish•Ionetix
•11 Aug 2026 06:37

Primer: Ionetix (IONTX US) - Aug 2026

Ionetix is a vertically integrated radiopharmaceutical company with a unique competitive advantage in its proprietary superconducting cyclotron...

Logo
100 Views
Share
bearish•Ionetix
•10 Aug 2026 16:03

Ionetix (IONTX US): Synthetic Expert Call Transcript (10 Aug 2026)

Cardiac PET Market Realities: While N-13 Ammonia has superior clinical performance, its 10-minute half-life forces a decentralized, on-site...

Share
bullish•Ionetix
•09 Aug 2026 10:08

IPO Databook: Ionetix (US) - Aug 2026

Ionetix Corporation develops superconducting cyclotron technology for medical and industrial applications, generating revenue from diagnostic and...

Share
No more insights
x